Volume 31, Issue 3

Search all Breast Cancer articles

May 2024

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
Masaya Hattori
Naoko Honma
Yutaka Yamamoto
Special Article Open access 04 March 2024 Pages: 335 - 339
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment
Yutaka Yamamoto
Chikako Yamauchi
Shigehira Saji
Special Article Open access 03 April 2024 Pages: 340 - 346
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition
Michio Yoshimura
Chikako Yamauchi
Shigehira Saji
Special Article Open access 05 April 2024 Pages: 347 - 357
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer
Xue Hu
Review Article 14 March 2024 Pages: 358 - 370
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models
Hongyan Zheng
Lihua Wu
Ge Lou
Original Article 30 January 2024 Pages: 371 - 381
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer
Kazuhiko Sato
Hiromi Fuchikami
Masahiro Kato
Original Article 15 February 2024 Pages: 382 - 390
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants
Nalee Kim
Won Kyung Cho
Haeyoung Kim
Original Article 18 February 2024 Pages: 391 - 400
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan
Yasue Tsuchida
Naoki Niikura
Naoki Hayashi
Original Article 07 March 2024 Pages: 401 - 408
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer
Kumiko Kida
Akimitsu Yamada
Takashi Ishikawa
Original Article 08 March 2024 Pages: 409 - 416
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer
Jin-hui Ye
Jian Yu
Yue-mei Mo
Original Article Open access 01 April 2024 Pages: 417 - 425
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB
Guo Li
Xinyue Lin
Zhichao Fu
Original Article 12 March 2024 Pages: 426 - 439
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β
Monalisa Parija
Surya Prakash
Sandip K. Mishra
Original Article 29 February 2024 Pages: 440 - 455
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap
Joep A. F. van Rooij
Ennie Bijkerk
Stefania M. H. Tuinder
Original Article Open access 06 April 2024 Pages: 456 - 466
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile
Danbee Kang
Seri Park
Yeon Hee Park
Original Article 12 March 2024 Pages: 467 - 475
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer
Kazutaka Narui
Toshihiko Satake
Itaru Endo
Original Article 21 March 2024 Pages: 476 - 484
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer
Kim Vo
Colton Ladbury
Arya Amini
Original Article Open access 20 March 2024 Pages: 485 - 495
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020
Ewe Seng Ch’ng
Original Article 28 March 2024 Pages: 496 - 506
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy
Hiroko Nogi
Akiko Ogiya
The Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society
Original Article Open access 04 April 2024 Pages: 507 - 518
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy
Dan Lin
Kathleen M. Sturgeon
Cheryl L. Thompson
Original Article 02 April 2024 Pages: 519 - 528
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer
Sean M. Hacking
Gabrielle Windsor
Yihong Wang
Rapid Communication 13 February 2024 Pages: 529 - 535
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.
Reiko Fukui
Takahiro Watanabe
Yasuo Miyoshi
Letter to the Editor 04 March 2024 Pages: 536 - 538

Volume 31, Issue 3

Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition

The role of the BTLA–HVEM complex in the pathogenesis of breast cancer

Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models

Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer

Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants

Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan

A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer

The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer

Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB

SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β

The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap

Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer

Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer

Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020

Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy

Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy

A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer

Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.

Navigation